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Abstract
The de novo origin of a new protein-coding gene from non-coding DNA is considered to be a very rare occurrence in
genomes. Here we identify 60 new protein-coding genes that originated de novo on the human lineage since divergence
from the chimpanzee. The functionality of these genes is supported by both transcriptional and proteomic evidence. RNA–
seq data indicate that these genes have their highest expression levels in the cerebral cortex and testes, which might
suggest that these genes contribute to phenotypic traits that are unique to humans, such as improved cognitive ability. Our
results are inconsistent with the traditional view that the de novo origin of new genes is very rare, thus there should be
greater appreciation of the importance of the de novo origination of genes.
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Introduction
The origin of new genes has always been an intriguing
evolutionary question [1]. New genes play significant roles in the
evolution of lineage specific phenotypes and adaptive innovation
[2]. The origin of genes can involve gene duplication, exon
shuffling, retroposition, mobile elements, lateral gene transfer,
gene fusion/fission, and de novo origination [1]. The mechanisms
for many of these processes have been extensively studied;
however, studies focused on de novo origination are few, and it
is commonly considered to be a very rare process [3,4].
In 1970, Susumu Ohno proposed that new genes arise from
existing genes, and that the de novo gene origination of a gene
from a random sequence would be highly unlikely [3]. Francois
Jacob even claimed that ‘‘the probability that a functional protein
would appear de novo by random association of amino acid is
practically zero’’ in a paper he published in 1976 [4]. Today, we
know that this evolutionary process is not impossible. For the de
novo origin of a protein-coding gene two steps are needed [2,5]:
(1), the DNA must be transcriptionally active, and (2) it must
evolve a translatable open reading frame; however, these two steps
can occur in either order. Pioneering research in 2006 clearly
showed that new genes could originate from non-coding sequences
in Drosophila. Levine et al. identified five novel genes in Drosophila
melanogaster that were derived from non-coding DNA [6]. These
Drosophila genes were found to be expressed predominantly in the
testes, and four of them were X-linked [6]. Similarly, Begun et al.
found that the Acp genes, which code for small proteins in
Drosophila, originated from noncoding DNA [7]. Over the next few
years, there were several additional reports of the characterization
of de novo-originated Drosophila genes [8–10]. In particular, Zhou
et al. (2008) identified nine genes that originated de novo through
a systematic search strategy, and proposed that the de novo origin
of genes plays an important role in the origination of new genes,
and estimated that about 11.9% of the new genes that originated
in the Drosophila lineage had arisen de novo [10], however, it is
unclear whether all of these new Drosophila genes encode proteins.
In 2009, Knowles and McLysaght identified three putative protein
coding genes: CLLU1, c22orf45, and DNAH10OS, which had a de
novo origin in the human genome. These genes were identified by
employing a straightforward, but rigorous, procedure which
provided transcriptional and translational evidence, and allowed
them to estimate that about 0.075% of the human protein coding
genes may have originated de novo from noncoding regions [5]. Li
et al. (2010) described another de novo protein-coding gene:
C20orf203, which is associated with brain function in humans [11].
Additional searches for de novo genes have resulted in the
identification of two protein coding genes by Cai et al. [12] and Li
et al. [13] in the Saccharomyces cerevisiae genome, a gene by Heinen
et al. in Mus musculus that arose de novo within the past ,2.5–3.5
million years in a large intergenic region [13], a gene in rice [14],
at least 13 protein-coding genes by Yang and Huang in the
Plasmodium vivax genome [15], and a Drosophila gene, Noble,i na
recent study by Gontijo et al. (2011) [16]. Despite all of these
studies, the de novo origin of new protein-coding genes from non-
coding DNA region in the genome is still considered to be a very
rare event.
The advent of large-scale genome sequencing has resulted in the
bioinformatic prediction of many lineage-specific genes in
genomes, suggesting that there may be a significant rate of de
novo origin for genes. A large proportion of these genes, however,
are likely falsely predicted genes [17,18] and the true numbers of
functional de novo originated genes remains unclear. While gene
duplication certainly plays a role in the origin of new genes [3], we
hypothesized that the rate of de novo gene origination is not
extremely low and also plays an important role in the origin of new
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identified 60 de novo-originated protein-coding genes in the
human lineage, including 27 genes identified based only on genes
found in Ensembl version 56, and 33 genes identified based on the
genes that were now excluded in version 56 of Ensembl, but were
present in versions 40–55 of the human genome. Each of these
new genes has both transcriptional and proteomic evidences
supporting their functionality. The number of de novo genes that
we found in the human genomes is much higher than that
expected based on previous estimates of the rate of de novo
origination, therefore, we suggest that a greater appreciation of de
novo origination of genes is needed.
Results
Search for De Novo-Originated Genes in the Human
Lineage
We performed a simple, conservative, but systematic pipeline to
search for genes that originated de novo in the human genome
since divergence from the chimpanzee (Figure 1). All human
protein sequences were searched using BLASTP against the
protein databases of other primates, i.e. chimpanzee, orangutan,
rhesus macaque, and marmoset, with orthologs identified using an
E-value threshold of 10
210. After the BLAST procedure and
excluding proteins shorter than 100 amino acids and short protein
sequences from alternatively spliced genes, we retrieved 584 genes
from the human genome that did not have a hit in other primates.
Human sequences that did not have a start (i.e., ATG) or stop
codons were excluded and the remaining 352 genes were searched
using BLAT against the chimpanzee and orangutan genomes in
the UCSC database (http://genome.ucsc.edu/, [19]) to identify
orthologous sequences. In addition to the bioinformatic analyses
all of the sequences underwent extensive manual checks. Human
genes for which an orthologous gene region (i.e., highly similar
sequences) could not be identified in the chimpanzee or orangutan
were discarded. Genes that had many duplicates in the human
genome were also discarded. To be a candidate de novo originated
gene, in addition to having a potentially translatable open reading
frame in the human genome, the gene must have been present,
and disrupted (i.e., non-translatable), in both the chimpanzee and
orangutan genomes, e.g., the chimpanzee and orangutan sequenc-
es must lack an ATG start codon or have frameshift-inducing
indels or nucleotide differences that result in a premature stop
codon. Chimpanzee and orangutan sequences lacking only an
ATG start codons were searched to determine whether they had
alternative start codons, either upstream or downstream of the
human ATG that could generate frame complete translatable
open reading frames. Chimpanzee or orangutan genes that
possessed premature stop codons but retained predicted protein
lengths longer than 80% of the human proteins were discarded for
analysis, while those with predicted proteins that were shorter than
80% of the size of the human proteins were kept for the analysis of
human de novo genes (see Dataset S1). To exclude the possibility
that the new gene had been generated in the primate ancestor and
then lost in parallel in both the chimpanzee and orangutan
lineages we searched for human specific mutations that were
responsible for generating the completed protein-coding open
reading frame. Only those genes that had a human specific
mutation that generates an open reading frame and where both
the chimpanzee and orangutan retained the ancestral state at these
positions, thus disrupting the open-reading frame, were kept (see
Dataset S2). These stringent criteria yielded a set of 46 genes.
Lastly, the coding sequences of these 46 putative de novo human
genes were used as queries in searches of databases for evidence of
expression at the mRNA and protein level. Expression at the
mRNA level was assessed by BLASTN searches of the NCBI
(http://www.ncbi.nlm.nih.gov/) nr (non-redundant) database, to
search the corresponding matched expressed mRNA sequence,
and the UCSC (http://genome.ucsc.edu/) EST database, to
search for short expressed sequence tags. Evidence for the
existence of the protein was obtained through searches of two
proteomic databases, PRIDE [20] and PeptideAtlas [21] (Dataset
S3). The PRIDE and PeptideAtlas databases are composed of
peptide sequences derived from proteomic experiments. Searches
of these databases resulted in the identification of 27 novel human
genes that have matching expressed mRNA sequences in the
GenBank or UCSC databases, thus must be transcribed, and also
have evidence for being translated as they have matching peptides
from the proteomic databases (Table S1). The mRNA evidence
suggests that none of these human genes have splice variants.
Intriguingly, CLLU1, c22orf45, and DNAH10OS, three human
genes identified as having a de novo-origin by Knowles and
McLysaght [5] were not found by our search. Knowles and
McLysaght [5] had used protein data from version 46 of Ensembl
for their study while we use sequence data from version 56.
c22orf45 and DNAH10OS were no longer annotated as genes in
version 56 of Ensembl, however CLLU1 still was. The peptide,
PAp00140670 (HIIYSTFLSK), that supported the translation of
CLLU1, though, is no longer present in the current build of
PeptideAtlas [21], yet the peptides that support the translation of
c22orf45 and DNAH10OS still remain in the proteomic database.
Thus the absence of a supporting peptide, for CLLU1, and the
absence of annotated genes, for c22orf45 and DNAH10OS,
prevented our approach from identifying these three previously
identified genes as having a de novo origin. Given the differences
in protein content between versions 46 and 56 of Ensembl, we
therefore identified protein sequences that had been present in
previous versions of the human genome (Ensembl versions 40–55)
but were no longer annotated as gene products in version 56.
These human protein sequences were then used in BLASTP
searches against other primate protein databases, adopting the
same pipeline that we described above, resulting in the
identification of an additional 33 de novo-originated protein
coding genes that are supported by human expression and
proteomic data (Figure S1, Table S2, Dataset S1, Dataset S4
and Dataset S5). Of the three de novo genes, CLLU1, c22orf45, and
DNAH10OS, identified by Knowles and McLysaght [5], only
DNAH10OS (ENSG00000204626) was identified in our study. As
Author Summary
The origin of genes can involve mechanisms such as gene
duplication, exon shuffling, retroposition, mobile elements,
lateral gene transfer, gene fusion/fission, and de novo
origination. However, de novo origin, which means genes
originate from a non-coding DNA region, is considered to
be a very rare occurrence. Here we identify 60 new
protein-coding genes that originated de novo on the
human lineage since divergence from the chimpanzee,
supported by both transcriptional and proteomic evi-
dence. It is inconsistent with the traditional view that the
de novo origin of new genes is rare. RNA–seq data indicate
that these de novo originated genes have their highest
expression in the cerebral cortex and testes, suggesting
these genes may contribute to phenotypic traits that are
unique to humans, such as development of cognitive
ability. Therefore, the importance of de novo origination
needs greater appreciation.
De Novo Origin of Protein-Coding Genes
PLoS Genetics | www.plosgenetics.org 2 November 2011 | Volume 7 | Issue 11 | e1002379described above, peptide PAp00140670 (HIIYSTFLSK) that
supported the translation of CLLU1 is no longer present in the
current build of PeptideAtlas, thus does not meet our criteria of a
de novo gene with transcription and translation evidence. The
orangutan genome predicts a gene sequence orthologous to
c22orf45 that has a complete translatable open reading frame,
suggesting that it has a much earlier origin. It is important to note
that the sequences of all of our 60 predicted de novo genes, 27
from the original screen and 33 from our subsequent screen are
present in the most current version of the human genome
(GRCh37/hg19), thus all 60 genes were kept for our subsequent
analyses.
We identified a total of 60 protein-coding genes that originated
de novo on the human lineage since divergence from chimpanzee.
Each of these new genes is found as a single copy coding gene,
with no other highly similar coding sequence in the human
genome, indicating that they were not generated by gene
duplication in the human genome. In addition, the orthologous
sequences in the chimpanzee and orangutan genomes are found as
single copies (except ENSG00000230294 which has two ortholo-
gous copies in the orangutan, but both of these sequences are
disrupted, see Dataset S2 for sequence alignment). Pairwise
divergences between the sequences were consistent with the
accepted one-to-one orthologous relationships between human,
chimpanzee, and orangutan. All of the de novo genes were found
to be composed of a single exon, with the exception of
ENSG00000204292, which has two. Only one of the genes is
located on the X-chromosome; the remainders appear to be
distributed randomly to the autosomes.
To determine whether these new genes are fixed in human
population, we searched the human population polymorphism
data in HapMap (Phases I, II, and III, http://hapmap.ncbi.nlm.
nih.gov/). There was no evidence for deletion or insertion of any
of the genes from the HapMap data. Only one of the genes,
ENSG00000206028, was found to have a SNP causing a
premature translation stop. This observation suggests that
ENSG00000206028 has not been fixed in the human population.
Our finding of 60 de novo genes, 59 of which are fixed in the
human population, suggests that the de novo origin of protein
coding genes on the human lineage is not a rare event. Since the
chimpanzees and humans shared a common ancestor ,5–6
million years ago, this indicates that the rate of origin of de novo
genes is ,9.83–11.8 genes per million years, an estimate that is
much higher than previously reported [5,10,22].
Expression Analysis by RNA–Seq
To gain insight into the potential functions of these de novo
originated genes we examined the expression of these genes using
RNA-seq data. RNA-Seq is a recently developed approach for
transcriptome profiling using high-throughput sequencing tech-
nologies, and is powerful for detecting the expression of genes [23].
Here, we examined the expression of the de novo originated genes
using previously described RNA-seq align data [22,23] from 11
human tissues: adipose, whole brain, cerebral cortex, breast, colon,
heart, liver, lymph node, skeletal muscle, lung and testes. Since the
exact transcripts for the de novo genes had not been defined, we
defined the expression level of these genes as the numbers of
unique RNA-seq reads that map to the coding region divided by
the length of the coding region, instead of typically used number of
reads mapping to a transcript divided by transcript length.
Evidence for expression, i.e., the mapping of reads, was found in
the RNA-seq data for 53 of the 60 genes. Expression data for the 7
Figure 1. Pipeline for the identification of de novo originated protein-coding genes in the human genome. BLASTP searches of human
protein sequences against proteins of other primates identified 548 human genes without protein orthologs. After excluding these genes having no
start or stop codons, 352 human coding sequences were used in BLAT searches to find orthologous genes in chimpanzee and orangutan and these
sequences were examined to confirm the presence of disrupting mutations. 66 genes with disrupted open reading frames in chimpanzee and
orangutan were examined to identify those with human-specific mutations that generate intact open reading frames, resulting 46 candidates. These
genes were used as queries of mRNA and proteomic databases to confirm transcription and translation. The pipeline yielded 27 de novo originated
protein-coding genes.
doi:10.1371/journal.pgen.1002379.g001
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other sources (e.g., EST data) in the NCBI database. Of these
seven genes, three had evidence of expression in tissues other than
the 11 tissues represented by the RNA-seq data, and four had
evidence for expression in the brain, testis or lung. The failure to
find evidence for expression of these four genes with RNA-seq
data, despite evidence from the NCBI data, may suggest that these
genes are expressed are a very low level in these tissues, or the site
of expression of the NCBI data may be incorrect (e.g., due to
contamination by other tissue). Typically, the expression levels of
the de novo originated genes are very low. The mean level of gene
expression, as defined by the number of reads mapping to these
genes divided by the total length of their coding sequences, is
highest in the testes, and second highest in the cerebral cortex
(Figure S2). After normalizing for the numbers of valid reads,
highest expression was still found in the testes, and the second in
the cerebral cortex (Figure 2A). Interestingly, the tissue that had
the largest proportion of the de novo genes expressed was the
cerebral cortex, with the second being the testes (Figure 2B).
Normalized expression levels of the 53 genes with RNA-seq
expression data for the 11 tissues were sorted from highest to
lowest. The proportion of genes having highest expression level in
the tissue, which was defined as the numbers of genes having
highest expression level in the tissue divided by total gene number
(i.e. 53), was highest in cerebral cortex followed by the testes
among these 11 tissues (Figure 2C); however, a similar pattern was
not observed for the proportion of genes having second, third, or
fourth highest levels of expression (Figure S3). In addition, we also
obtain these patterns of the genome wide genes, and normalized
these values of de novo genes by dividing the values of genome
wide genes. In consistent, the level of gene expression, normalized
expression level and the proportion of genes having expression
Figure 2. Levels of expression of de novo genes in 11 tissues. (A) Mean normalized expression levels of de novo originated genes in 11 tissues
are defined by the mean level of expression as the numbers of unique reads mapping to coding regions divided by the total length of all the coding
regions, divided by the total number of valid reads in the samples (610
28). The vertical axis represents value of mean the normalized expression
levels and abscissa axis represents the 11 tissues. (B) The proportion of the de novo originated genes that have expressed reads in the 11 tissues. The
vertical axis represents the values of proportion, and abscissa axis represents the 11 tissues. (C) The proportion of the de novo originated genes
having their highest normalized expression levels in each of the 11 tissues. The vertical axis represents the values of proportion, and abscissa axis
represents the 11 tissues.
doi:10.1371/journal.pgen.1002379.g002
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the proportion of genes having highest expression level (Figure S4).
Several genes were found to have intriguing expression patterns
(Figure S5). For example, gene ENSG00000187488 is highly
expressed in the testes and thus we speculate that this gene may
have a role in reproduction. ENSG00000206028 is highly, and
specifically, expressed in the cerebral cortex, suggesting that this
gene may contribute to the development of the human brain and
associated cognitive abilities.
Evolutionary Rate of the New Genes on the Human
Lineage
To determine whether the de novo genes had come under
selective constraints, which would indicate that they had acquired
a function, we examined the rate of sequence evolution of these
genes. Substitution rates for these sequences were calculated for
both the human and chimpanzee lineages and these rates were
compared to the genome-wide average rate for genes. The
substitution rate for de novo genes was found to be higher than the
genome-wide average rate on both the human and chimpanzee
lineages (Figure 3), with the chimpanzee sequences evolving at the
highest rate. The chimpanzee sequences were expected to evolve
at a high rate, as these sequences should act as non-coding
sequences rather than genes. The human sequences also evolved
at an elevated rate, but at a rate that was slightly lower than that
seen on the chimpanzee lineage. This observation is not an
unexpected result if these had become functional genes as these
new genes originated very recently from non-coding regions on the
human lineage, and thus should have been under selection for only
part of the time since divergence from chimpanzee, and thus
should have a rate higher than the genome-wide average, but
lower than the chimpanzee lineage. In addition, young genes have
been found to tend to be the subject of weaker purifying selection
[24], thus should have higher substitution rates.
Discussion
Here, we discovered 60 genes that originated de novo on the
human lineage, with 59 of them being fixed in the human
population. This number of genes implies a rate of de novo
generation of ,9.83–11.8 genes per million years, a rate much
higher than previously proposed rates [5,10,22]. Despite this high
rate, when the rate is expressed in terms of per gene, ,0.00033–
0.00039 per gene per million years, it is still a lower rate than the
rate of new gene origin by gene duplication [25,26]. Our estimated
rate, though, for de novo origin may be underestimated due to the
conservativeness of our pipeline. First, as described above, in our
pipeline, translatable open reading frames must have been
complete in the human genome and disrupted in both the
chimpanzee and orangutan genomes to be candidates as a de novo
gene. Genes that did not have a clear ortholog (i.e., a sequence
with very high similarity) in either the chimpanzee or the
orangutan genomes (both of which are less complete than the
human genome, and thus could be a missing genes) were not used.
It is also often difficult to determine whether a protein-coding gene
originated specifically on the human lineage or if it originated in a
primate ancestor but was then lost on both the chimpanzee and
orangutan lineages. The conservativeness of our pipeline thus only
allowed us to accept genes where we could clearly show human
specific mutations generated complete protein-coding reading
frames, and that these were conserved for disrupting state in both
the chimpanzee and orangutan genomes. As both the chimpanzee
and orangutan sequences should be non-functional sequences, and
thus not under selection, there is a reasonable likelihood that a
second mutation, in addition to the human open reading frame
completing mutation, could have occurred in the chimpanzee or
orangutan that would prevent us for identifying these genes as
having a de novo origin on the human lineage. A total of 69 genes
(20 shown in Figure 1 and 49 in Figure S1) were excluded from
our analysis as the ancestral state of the human specific mutation
was not conserved in chimpanzee and orangutan. Second, we used
only two proteomics databases: PRIDE [20] and PeptideAtlas [21]
to show that these genes were translated; however, proteomic data
is still limited in terms of tissues and developmental stages sampled
and evidence for the protein products of some genes is likely
lacking from the current versions of these databases. Here, 56
genes having human specific mutations but no supported peptide
evidence were excluded. More diverse proteomic datasets may
demonstrate that additional de novo originate genes are indeed
protein coding.
RNA-seq expression data suggest potential functions for some of
the de novo originated protein-coding genes. De novo genes show
higher expression in the cerebral cortex relative to other examined
tissues. The brain is responsible for cognitive abilities that occur
primarily in the cerebral cortex which is the furrowed gray matter
covering the cerebral hemispheres [27]. The cerebral cortex plays
key roles in learning, memory, language, thought, emotion,
perceptual awareness, and consciousness [27]. Great efforts have
been made to explore the origin and evolution of human cognitive
ability [28], including examining the contributions of positive
natural selection on brain development genes [29] and changes in
the expression [30–32] and alternative splicing of genes expressed
in the brain [33]. Our results provide new information for the field
and suggest that de novo originated genes may also be responsible
for some of these characters.
Many new genes, generated by diverse mechanisms including
gene duplication, chimeric origin, retrotransposition, and de novo
origin, are specifically expressed or function in the testes [6,34–38]
(reviewed in [2]). Henrik Kaessmann hypothesized that the testis is
a catalyst and crucible for the birth of new genes in animals [2].
First, the testes is the most rapidly evolving organ due in part to its
roles in sperm competition, sexual conflict, and reproductive
isolation [2]. Second, Henrik Kaessmann speculated that the
chromatin state in spermatocytes and spermatids should facilitate
the initial transcription of newly arisen genes [2]. The reason for
Figure 3. Rate of evolution of de novo originated genes. Rate of
de novo originated genes on the human lineage and orthologous
sequences on the chimpanzee lineage are compared to the average
genome wide genes. Lineage specific substitution rates (+standard
deviation) of the de novo genes and genome-wide genes are
presented.
doi:10.1371/journal.pgen.1002379.g003
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promoter sequences and the presence of modified histones in
spermatocytes and spermatids [39], causing an elevation of the
levels of components of the transcriptional machinery, permitting
promiscuous transcription of nonfunctional sequences, including
de novo originated genes.
While this study has resulted in the identification of 60 novel
human genes, and emphasized the underappreciated role of de
novo origin of genes, there are several important caveats to our
study. First, the protein evidence is based on only two proteomic
databases: PRIDE [20], and PeptideAtlas [21], both of which have
many limitations. For example, the sampling of proteomic
databases are still limited to a small number of tissues and
developmental stages, and problems with sample contamination
still need to be resolved [40]. As larger and better proteomic
databases become available the evidence in support of the
translation of these novel genes will be strengthened. Second,
many of these new genes are expressed at very low levels in the 11
tissues that had available RNA-seq data. These results indicate
that many of these genes may play only weak biological roles, or
that their functions are not well established.
Materials and Methods
Identification of De Novo-Originated Genes in the
Human Lineage
Human protein sequences from Ensembl version 56 were used
as queries for BLASTP [21] searches against the proteins of
chimpanzee, orangutan, rhesus macaque, and marmoset with
significant hits being those with an E-value lower than 10
210. The
coding sequences of the human proteins that did not record a
significant BLAST hit against any of the other primate genomes
were used as queries in BLAT searches of the chimpanzee,
orangutan genomes to identify orthologous sequences. Non-
human primate sequences that contained a frame-shift or
premature stop codon that prevented the translation of a protein
of at least 80% of the size of the human predicted proteins were
considered to be non-protein coding. BLASTN searches with the
human coding sequences against the nr (non redundant) database
in the NCBI were used to identify matching expressed mRNA
sequences. EST database download from UCSC (http://genome.
ucsc.edu/) was also searched by BLASTN for expression evidence.
We searched two proteomics databases: PRIDE [20] and
PeptideAtlas [21] (2010-05), to determine whether a candidate
de novo-originated gene had known exact match peptide data.
The peptides in these proteomic databases had been identified by
a variety of methods from diverse healthy cells, tissues, and fluids.
Characterization of Expression Patterns for New Genes by
RNA–Seq
The recently developed RNA-seq technique has proven to be a
powerful approach to detect the expression of genes [23]. RNA-
seq data from 11 human tissues: adipose, whole brain, breast,
colon, heart, liver, lymph node, skeletal muscle and testes were
obtained [41] and downloaded from NCBI with accession code
GSE12946, and from cerebral cortex and lung from [42] with
NCBI accession code GSE13652. Only reads that mapped to a
unique location in the genome were considered. Since the exact
transcriptional units of these new genes has not been defined, the
expression level of the genes was defined as the numbers of unique
reads mapping to the coding region divided by the length of the
coding region. Expression levels were normalized by dividing by
the total number of valid reads in the samples. Expression levels of
19,800 human genes evaluated by RNA-seq data described above
in the 11 tissues, which were obtained from study [43], were used
to evaluate genome wide expression pattern. In the study the
expression level of a gene in a tissue was defined by the number of
valid hits to the gene divided by the effective length of the gene,
then was normalized by dividing the total number of valid hits in
the tissue [43].
Calculation of Evolutionary Rate in the Human Lineage
To calculate the evolutionary rates of sequence we used an
approach similar to that used in a previous study [44]. Human
protein sequences were used to identify one-to-one orthologous
genes with BLASTP searches against the chimpanzee and
orangutan protein sequences. Reciprocal searches were performed
using the chimpanzee and orangutan proteins to query the human
proteins to confirm orthology. A total of 16,126 proteins with
reciprocal best hits in both human/chimpanzee and human/
orangutan searches were retained for further analysis. Orthologs
with sequences containing ‘‘X’’ amino acid for ‘‘N’’ in the coding
sequences were excluded. Sequences of orthologs were aligned by
ClustalW [45]. To exclude incorrect alignments and nonortholo-
gus regions from alignments, we used a sliding window of 5 amino
acids, moved the sliding window by one codon for each step, to
examine the quality of the alignments. If the aligned human and
chimpanzee sequences within a window have a similarity #20%,
then the orthologs were discarded. Finally, protein sequence with
the longest amino acid alignments were retained for each gene,
and alignments containing ,100 amino acids were discarded. A
total of 14,050 one-to-one orthologous genes among human,
chimpanzee, and orangutan were identified. The baseml program,
implemented in the PAML package, with the HKY85 substitution
model was used to calculate the substitution rates in the human
and chimpanzee lineage for each gene [46]. Genes that had a
substitution rate on the human or chimpanzee lineage of greater
than 0.1 were discarded.
Supporting Information
Figure S1 Our pipeline to search for de novo originated protein-
coding genes in human genomes based on protein sequences that
were present in previous versions of the human genome (Ensembl
versions 40–55) but no longer present in version 56. BLASTP
searches of human protein sequences against proteins of other
primates identified human 892 genes without protein orthologs.
After excluding these genes having no start or stop codons, 741
human coding sequences were used in BLAT searches to find
orthologous genes in chimpanzee and orangutan and these
sequences were examined to confirm the presence of disrupting
mutations. 139 genes with disrupted open reading frames in
chimpanzee and orangutan were examined to identify those with
human-specific mutations that generate intact open reading
frames, resulting 90 candidates. These genes were used as queries
of mRNA and proteomic databases to confirm transcription and
translation. The pipeline yielded 33 additional de novo originated
protein-coding genes that had not been identified in Figure 1.
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Figure S2 Mean expression level of de novo originated genes in
11 tissues. The mean expression level is defined by the numbers of
unique reads mapped to all the coding regions divided by the total
length of the coding regions, in 11 tissues.
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Figure S3 Proportion of genes having second (A), third (B), and
fourth (C) highest expression levels in each tissue.
(PDF)
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originated genes that have expressed reads divided by the
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Figure S5 Two genes with special expression patterns. The
mean normalized expression levels of de novo originated genes in
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of valid reads in the samples (610
28).
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